Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers caused by Epstein-Barr Virus (EBV), in the paper, "USP7 inhibitors destabilize EBNA1 and suppress EBV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback